Cipher Pharma Q2 EPS $0.15 Misses $0.19 Estimate, Sales $12.067M Miss $13.606M Estimate
Cipher Pharma (TSX:CPH) reported quarterly earnings of $0.15 per share which missed the analyst consensus estimate of $0.19 by 21.05 percent. This is a 31.82 percent decrease over earnings of $0.22 per share from the
Cipher Pharma made less money than experts expected this quarter—both their profit per share and total sales came in below what people predicted. When a company misses these targets, it might mean they're facing challenges, so it's worth watching to see if things improve next quarter.
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.